A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT02605785
Status
Recruiting
Apply to this trial

Conditions

  • Progressive Supranuclear Palsy

Eligibility Criteria

Sex
ALL
Age
35 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • F-18 AV 1451 — DRUG
    Tau PET scan

Study Details

This study is designed to learn more about overall tau burden in the brain of patients with Progressive Supranuclear Palsy (PSP).

Key Dates

Start date
Nov 30, 2015
Status verified
Apr 2026
Primary completion
Jan 31, 2030
Completion
Jan 31, 2030

Study Design

Enrollment
332 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Tau PET Scan, F-18 AV 1451
    All subjects will received a Tau PET scan.

Primary Outcome Measure

The investigators will be looking at the amount of Tau protein in the brain of patients with PSP. [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905
Sarah M Boland, CCRP
[email protected]
507-284-3863

Find similar trials in Rochester, MN

By research site
Mayo Clinic· Rochester, MN

Related Studies